Quarterly report [Sections 13 or 15(d)]

Consolidated Statements of Changes in Net Assets

v3.26.3
Consolidated Statements of Changes in Net Assets - USD ($)
$ in Thousands
 1 Months Ended 3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2026
Jun. 30, 2026
Mar. 31, 2026
Sep. 30, 2025
Jun. 30, 2025
Mar. 31, 2025
Sep. 30, 2026
Sep. 30, 2025
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Balance at beginning of period (in shares)       46,588,608       46,588,608  
Balance at beginning of period   $ 748,800 $ 719,528 $ 738,659 $ 722,788 $ 718,940 $ 624,903 $ 738,659 $ 624,903
Issuances of common stock, net of underwriting and offering costs             90,532    
Dividend reinvestment (in shares)               0 893,443
Dividend reinvestment         4,596 4,679 4,496 $ 0 $ 13,771
Common stock repurchased (in shares) (53,778)                
Common stock repurchased $ (670) (671)   (16,030) (2,539) (146)      
Net increase in net assets resulting from operations   18,146 29,272 13,223 26,529 16,289 15,875 $ 60,641 58,693
Dividends to stockholders   $ (16,324)   (16,324) (17,016) (16,974) (16,866)    
Balance at ending of period (in shares) 45,291,451 45,291,451           45,291,451  
Balance at ending of period $ 749,951 $ 749,951 $ 748,800 $ 719,528 $ 734,358 $ 722,788 $ 718,940 $ 749,951 $ 734,358
Common Stock                  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Balance at beginning of period (in shares)   45,345,229 45,345,229 46,588,608 47,148,802 46,849,531 40,240,358 46,588,608 40,240,358
Balance at beginning of period   $ 45 $ 45 $ 47 $ 47 $ 47 $ 40 $ 47 $ 40
Issuances of common stock, net of underwriting and offering costs (in shares)             6,325,000    
Issuances of common stock, net of underwriting and offering costs             $ 6    
Dividend reinvestment (in shares)         299,994 309,276 284,173    
Dividend reinvestment             $ 1    
Common stock repurchased (in shares)   (53,778)   (1,243,379) (180,769) (10,005)      
Common stock repurchased   $ 0   $ (2)          
Balance at ending of period (in shares) 45,291,451 45,291,451 45,345,229 45,345,229 47,268,027 47,148,802 46,849,531 45,291,451 47,268,027
Balance at ending of period $ 45 $ 45 $ 45 $ 45 $ 47 $ 47 $ 47 $ 45 $ 47
Additional Paid-In Capital                  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Balance at beginning of period   765,979 765,979 782,007 789,134 784,601 689,580 782,007 689,580
Issuances of common stock, net of underwriting and offering costs             90,526    
Dividend reinvestment         4,596 4,679 4,495    
Common stock repurchased   (671)   (16,028) (2,539) (146)      
Balance at ending of period 765,308 765,308 765,979 765,979 791,191 789,134 784,601 765,308 791,191
Total Overdistributed Earnings                  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Balance at beginning of period   (17,224) (46,496) (43,395) (66,393) (65,708) (64,717) (43,395) (64,717)
Net increase in net assets resulting from operations   18,146 29,272 13,223 26,529 16,289 15,875    
Dividends to stockholders   (16,324)   (16,324) (17,016) (16,974) (16,866)    
Balance at ending of period $ (15,402) $ (15,402) $ (17,224) $ (46,496) $ (56,880) $ (66,393) $ (65,708) $ (15,402) $ (56,880)